SpectrumAi develops innovative solutions to improve life-changing therapies. SpectrumAi's initial focus is to modernize Applied Behavior Analysis (ABA) for children with autism by capturing and measuring objective treatment and outcomes data to understand quality drivers.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/16/23 | $20,000,000 | Series A |
Autism Impact Fund Cobalt Ventures CVS Health Ventures  F-Prime Capital Partners Frist Cressey Ventures | undisclosed |
